Inhibrx Biosciences/$INBX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Inhibrx Biosciences
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Ticker
$INBX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
159
ISIN
US45720N1037
Website
INBX Metrics
BasicAdvanced
$214M
0.13
$111.58
-
-
Price and volume
Market cap
$214M
52-week high
$17.09
52-week low
$10.80
Average daily volume
79K
Financial strength
Current ratio
5.119
Quick ratio
4.967
Long term debt to equity
110.709
Total debt to equity
112.798
Interest coverage (TTM)
-28.88%
Profitability
EBITDA (TTM)
-229.863
Gross margin (TTM)
-100,303.50%
Net profit margin (TTM)
861,485.50%
Operating margin (TTM)
-116,231.50%
Effective tax rate (TTM)
0.00%
Management effectiveness
Return on assets (TTM)
-107.28%
Return on equity (TTM)
4,118.34%
Valuation
Price to earnings (TTM)
0.133
Price to revenue (TTM)
1,128.491
Price to book
2.27
Price to tangible book (TTM)
2.27
Price to free cash flow (TTM)
-1.337
Free cash flow yield (TTM)
-74.77%
Free cash flow per share (TTM)
-1,105.91%
Growth
Revenue change (TTM)
-88.78%
Earnings per share change (TTM)
-613.11%
What the Analysts think about INBX
Analyst ratings (Buy, Hold, Sell) for Inhibrx Biosciences stock.
INBX Financial Performance
Revenues and expenses
INBX Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Inhibrx Biosciences stock?
Inhibrx Biosciences (INBX) has a market cap of $214M as of June 27, 2025.
What is the P/E ratio for Inhibrx Biosciences stock?
The price to earnings (P/E) ratio for Inhibrx Biosciences (INBX) stock is 0.13 as of June 27, 2025.
Does Inhibrx Biosciences stock pay dividends?
No, Inhibrx Biosciences (INBX) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Inhibrx Biosciences dividend payment date?
Inhibrx Biosciences (INBX) stock does not pay dividends to its shareholders.
What is the beta indicator for Inhibrx Biosciences?
Inhibrx Biosciences (INBX) does not currently have a Beta indicator.